HIGHLIGHTS
- who: Tanawat Attachaipanich and colleagues from the Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand have published the Article: Potential Roles of Melatonin in Doxorubicin-Induced Cardiotoxicity: From Cellular Mechanisms to Clinical Application, in the Journal: Pharmaceutics 2023, 15, 785. of 27/02/2023
- what: Evidence from both in_vitro and in_vivo studies demonstrates the potential benefits of melatonin on doxorubicin-induced cardiotoxicity.
- future: Studies on the anti-arrhythmic effect of melatonin on doxorubicin-induced cardiotoxicity are essentially needed to fully understand its mechanism and potential clinical . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.